This article was originally published here
J Am Soc Echocardiogr. 2020 Nov 16:S0894-7317(20)30718-5. doi: 10.1016/j.echo.2020.11.002. Online ahead of print.
ABSTRACT
BACKGROUND: Little is known about the timing of preclinical heart failure (HF) development, particularly among blacks. The primary aims of this study were to delineate age-related left ventricular (LV) structure and function evolution in a biracial cohort and to test the hypothesis that young-adult LV parameters within normative ranges would be associated with incident stage B-defining LV abnormalities over 25 years, independent of cumulative risk factor burden.
METHODS: We analyzed data from the Coronary Artery Risk Development in Young Adults Study. Participants (N=2,833) were 45% black, 56% female, with mean baseline age 30.1 years. We used generalized estimating equation logistic regression to estimate age-related probabilities of stage B LV abnormalities (remodeling, hypertrophy, or dysfunction) and logistic regression to examine risk-factor-adjusted associations between baseline LV parameters and incident abnormalities. We used Cox regression to assess whether baseline LV parameters associated with incident stage B LV abnormalities were also associated with incident clinical (stage C/D) HF events over >25 years follow-up.
RESULTS: Probabilities of stage B LV abnormalities at ages 25 and 60 years were 10.5% (95% CI, 9.4-11.8%) and 45.0% (42.0-48.1%), with significant race-sex disparities; e.g., at age 60: black men 52.7% (44.9-60.3%), black women 59.4% (53.6-65.0%), white men 39.1% (33.4-45.0%), and white women 39.1% (33.9-44.6%). Over 25 years, baseline LV end-systolic dimension/height was associated with incident systolic dysfunction (adjusted odds ratio per 1-SD higher: 2.56 [1.87-3.52]), eccentric hypertrophy (1.34 [1.02-1.75]), concentric hypertrophy (0.69 [0.51-0.91]), and concentric remodeling (0.68 [0.58-0.79]); baseline LV mass/height2.7 was associated with incident eccentric hypertrophy (1.70 [1.25-2.32]), concentric hypertrophy (1.63 [1.19-2.24]), and diastolic dysfunction (1.24 [1.01-1.52]). Among the entire cohort with baseline echocardiographic data available (N=4097; 72 HF events), LV end-systolic dimension/height and mass/height2.7 were significantly associated with incident clinical HF (adjusted hazard ratios per 1-SD higher: 1.56 [95% CI, 1.26-1.93] and 1.42 [1.14-1.75], respectively).
CONCLUSIONS: Stage B LV abnormalities and related racial disparities were present in young adulthood, increased with age, and were associated with baseline variation in indexed LV end-systolic dimension and mass. Baseline indexed LV end-systolic dimension and mass were also associated with incident clinical HF. Efforts to prevent the LV abnormalities underlying clinical HF should start from a young age.
PMID:33212181 | DOI:10.1016/j.echo.2020.11.002
See original here:
Age-Related Development of Cardiac Remodeling and Dysfunction in Young Black and White Adults: the Coronary Artery Risk Development in Young Adults...
- Managing Right Ventricular Failure in PAH: An Algorithmic Approach | Advances in ... [Last Updated On: April 13th, 2018] [Originally Added On: April 13th, 2018]
- What Is the Ejection Fraction? - Verywell Health [Last Updated On: May 12th, 2018] [Originally Added On: May 12th, 2018]
- Ventricular septal defect - Wikipedia [Last Updated On: June 21st, 2018] [Originally Added On: June 21st, 2018]
- Heart Failure Medication: Beta-Blockers, Alpha Activity ... [Last Updated On: July 7th, 2018] [Originally Added On: July 7th, 2018]
- Acute Management of Pulmonary Embolism - American College ... [Last Updated On: July 17th, 2018] [Originally Added On: July 17th, 2018]
- Ventricular Remodeling | Profiles RNS [Last Updated On: July 24th, 2018] [Originally Added On: July 24th, 2018]
- Left ventricular hypertrophy - Wikipedia [Last Updated On: August 20th, 2018] [Originally Added On: August 20th, 2018]
- Ventricular Remodeling Surgery (SVR) [Last Updated On: September 24th, 2018] [Originally Added On: September 24th, 2018]
- Left Ventricular Remodeling in Heart Failure | JACC ... [Last Updated On: November 25th, 2018] [Originally Added On: November 25th, 2018]
- Ventricular dysfunction in heart failure - Britannica.com [Last Updated On: December 25th, 2018] [Originally Added On: December 25th, 2018]
- TIMI Study Group - LEADERSHIP [Last Updated On: January 31st, 2019] [Originally Added On: January 31st, 2019]
- Ventricular Remodeling Procedure | Main Line Health ... [Last Updated On: February 24th, 2019] [Originally Added On: February 24th, 2019]
- BioLineRx Ltd. (BLRX)'s Financial Results Comparing With Coherus BioSciences Inc. (NASDAQ:CHRS) - Stocks Beat [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Reviewing Aeterna Zentaris Inc. (AEZS)'s and BioLineRx Ltd. (NASDAQ:BLRX)'s results - Stocks Beat [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Karuna Therapeutics Inc. (KRTX) and BioLineRx Ltd. (NASDAQ:BLRX) Comparing side by side - Stocks Beat [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Arbutus Biopharma Corporation (ABUS)'s Financial Results Comparing With BioLineRx Ltd. (NASDAQ:BLRX) - The EN Herald [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Cardiac Dimensions touts Carillon TMVR study - Mass Device [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF - TCTMD [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Cardiac Restoration Systems Market Will Make a Huge Impact in Near Future - Wolf Mirror [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Reduce Fmr Study Shows Cardiac Dimensions' Carillon System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure - TCTMD [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Heart Failure Society of America 2019: Virtual Visits, Spironolactone Issues, and Reasons to Worry - DocWire News [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- LV Reverse Remodeling Not Improved by SGLT-2 Inhibitor - DocWire News [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- BioLineRx Ltd. (BLRX)'s Financial Results Comparing With Soligenix Inc. (NASDAQ:SNGX) - CryptoCoinsTribune [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Biolinerx LTD. American Depositary Shares (NASDAQ:BLRX) Could Burn Your Long Portfolio After More Shorts - The MAK Daily [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Reviewing BioLineRx Ltd. (BLRX)'s and Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA)'s results - CryptoCoinsTribune [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Comparison of Protalix BioTherapeutics Inc. (PLX) and BioLineRx Ltd. (NASDAQ:BLRX) - MS Wkly [Last Updated On: October 19th, 2019] [Originally Added On: October 19th, 2019]
- Contrasting of BioLineRx Ltd. (BLRX) and Edge Therapeutics Inc. (:) - MS Wkly [Last Updated On: October 19th, 2019] [Originally Added On: October 19th, 2019]
- Contrasting of BioLineRx Ltd. (BLRX) and Protalix BioTherapeutics Inc. (NYSEAMERICAN:PLX) - The Broch Herald [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]
- BioLineRx Ltd. (BLRX)'s Financial Results Comparing With Cyanotech Corporation (NASDAQ:CYAN) - The Broch Herald [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]
- Triple-Gene Announces Completion of Enrollment and Dosing in Phase 1 Trial of INXN-4001, First Multigenic Investigational Therapeutic Candidate for... [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]
- Contrasting of BioLineRx Ltd. (BLRX) and Moderna Inc. (NASDAQ:MRNA) - The Broch Herald [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- Edited Transcript of MYOK earnings conference call or presentation 11-Nov-19 1:30pm GMT - Yahoo Finance [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- Cardiac Restoration Systems Market: Key Growth Factors and Industry Analysis 2018 - 2028 - The Market Expedition [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- Velocity Transfer Function In The Right Pulmonary Artery And Impaired | COPD - Dove Medical Press [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- 3 Stocks to Buy Ahead of the Next Market Crash - The Motley Fool [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival - TCTMD [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- Patients With Chemotherapy-Induced Cardiomyopathy Show Improvements in LVEF After Cardiac Resynchronization Therapy - AJMC.com Managed Markets Network [Last Updated On: December 4th, 2019] [Originally Added On: December 4th, 2019]
- BioVentrix Announces Publication of Positive One-Year Outcomes for Revivent TC System - Yahoo Finance [Last Updated On: December 4th, 2019] [Originally Added On: December 4th, 2019]
- Cardiac Restoration Systems Market Forecasted To Surpass The Value Of US$ XX Mn/Bn By 2055 2017 2025 - Weekly News Times [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- The Outer Line: The impact of endurance training on the cardiac health of women - VeloNews [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- Contrasting of Insmed Incorporated (INSM) and BioLineRx Ltd. (NASDAQ:BLRX) - The CoinGlobalist [Last Updated On: December 16th, 2019] [Originally Added On: December 16th, 2019]
- CARDIAC RESTORATION SYSTEMS MARKET ANALYSIS TRENDS, GROWTH OPPORTUNITIES, SIZE, TYPE, DYNAMIC DEMAND AND DRIVES WITH FORECASTS TO 2028 - Voice of... [Last Updated On: January 13th, 2020] [Originally Added On: January 13th, 2020]
- Early Expressed Circulating Long Noncoding RNA CHAST is Associated with Cardiac Contractile Function in Patients with Acute Myocardial Infarction -... [Last Updated On: January 13th, 2020] [Originally Added On: January 13th, 2020]
- Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone - DocWire News [Last Updated On: January 23rd, 2020] [Originally Added On: January 23rd, 2020]
- Increased Long-Term Risk for Venous Thromboembolism After Heart Failure - The Cardiology Advisor [Last Updated On: January 23rd, 2020] [Originally Added On: January 23rd, 2020]
- Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity - Science Advances [Last Updated On: February 1st, 2020] [Originally Added On: February 1st, 2020]
- Coronary Microvascular Dysfunction Found to Increase Risk for CV Events in Chronic Kidney Disease - The Cardiology Advisor [Last Updated On: February 1st, 2020] [Originally Added On: February 1st, 2020]
- New Data Confirms Cardiac Dimensions' Carillon System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation -... [Last Updated On: February 26th, 2020] [Originally Added On: February 26th, 2020]
- BioVentrix Announces Ralph Stephan von Bardeleben, MD, as Co- Principal Investigator of the REVIVE-HF Clinical Trial - Yahoo Finance [Last Updated On: March 5th, 2020] [Originally Added On: March 5th, 2020]
- Relationship between histopathological features of aspirated thrombi and long-term left ventricular function in patients with ST-segment elevation... [Last Updated On: March 15th, 2020] [Originally Added On: March 15th, 2020]
- FierceMedTech Names BioVentrix as One of Its "Fierce 15" Companies of 2019 - Yahoo Finance [Last Updated On: March 15th, 2020] [Originally Added On: March 15th, 2020]
- Causes and Prevention of Ventricular Remodeling After MI ... [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Left Ventricular Remodelling - ECR Journal [Last Updated On: April 23rd, 2020] [Originally Added On: April 23rd, 2020]
- Cardiac Restoration Systems Market to Make Great Impact in Near Future by 2026 - The Canton Independent Sentinel [Last Updated On: June 12th, 2020] [Originally Added On: June 12th, 2020]
- Multi-Society Guidelines on the Use of Multimodality CV Imaging in Competitive Athletes - The Cardiology Advisor [Last Updated On: June 12th, 2020] [Originally Added On: June 12th, 2020]
- Chronic PDE5i Treatment Found to Improve Cardiac Remodeling in Men, but Not Women, With Diabetic Cardiomyopathy - Endocrinology Advisor [Last Updated On: June 12th, 2020] [Originally Added On: June 12th, 2020]
- Acceleron to Host Conference Call and Webcast to Review Results of PULSAR Phase 2 Trial of Sotatercept Presented at American Thoracic Society 2020... [Last Updated On: June 23rd, 2020] [Originally Added On: June 23rd, 2020]
- American Heart Association and Barth Syndrome Foundation Partner to Address Rare Disease - PR Web [Last Updated On: August 29th, 2020] [Originally Added On: August 29th, 2020]
- The Association of Cardio-Ankle Vascular Index (CAVI) with Biatrial Remodeling in Atrial Fibrillation - DocWire News [Last Updated On: September 3rd, 2020] [Originally Added On: September 3rd, 2020]
- Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral... [Last Updated On: September 3rd, 2020] [Originally Added On: September 3rd, 2020]
- Sep 4 2020 This Week in Cardiology - Medscape [Last Updated On: September 5th, 2020] [Originally Added On: September 5th, 2020]
- Emerging treatment helps reverse heart failure in some patients - Science Codex [Last Updated On: October 27th, 2020] [Originally Added On: October 27th, 2020]
- GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial - PRNewswire [Last Updated On: October 27th, 2020] [Originally Added On: October 27th, 2020]
- North America to Outshine the Global Slowdown in Cardiac Restoration Systems market between 2020 and 2030 - The Think Curiouser [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- Adiponectin receptor 1 variants contribute to hypertrophic cardiomyopathy that can be reversed by rapamycin - Science Advances [Last Updated On: January 13th, 2021] [Originally Added On: January 13th, 2021]
- Longer Survival Seen in Heart Failure Stabilized Via Cardiac Resynchronization Therapy - The Cardiology Advisor [Last Updated On: April 13th, 2021] [Originally Added On: April 13th, 2021]
- Cardiac Dimensions Welcomes Robert White to its Board of Directors - PRNewswire [Last Updated On: April 13th, 2021] [Originally Added On: April 13th, 2021]
- [Full text] SIRT1 is Required for Exercise-Induced Beneficial Effects on Myocardia | JIR - Dove Medical Press [Last Updated On: April 13th, 2021] [Originally Added On: April 13th, 2021]
- Role of Pyroptosis in Diabetes and Its Therapeutic Implications | JIR - Dove Medical Press [Last Updated On: May 25th, 2021] [Originally Added On: May 25th, 2021]
- Epigenetic therapies for heart failure | VHRM - Dove Medical Press [Last Updated On: May 25th, 2021] [Originally Added On: May 25th, 2021]
- Are you at risk for sudden death, and can it be prevented? - Jamaica Observer [Last Updated On: May 25th, 2021] [Originally Added On: May 25th, 2021]
- Does a plant-based diet improve cardiac function? Here's the answer - Hindustan Times [Last Updated On: June 21st, 2021] [Originally Added On: June 21st, 2021]
- Early Use of Sacubitril/Valsartan Linked to Improved Cardiac Function Post AMI - AJMC.com Managed Markets Network [Last Updated On: November 5th, 2021] [Originally Added On: November 5th, 2021]
- Higher BP, LV Changes Seen in Children Conceived by ART - Medscape [Last Updated On: November 5th, 2021] [Originally Added On: November 5th, 2021]
- Regional Heterogeneity in Determinants of Atrial Matrix Remodeling and Association with Atrial Fibrillation Vulnerability Post-Myocardial Infarction -... [Last Updated On: January 26th, 2022] [Originally Added On: January 26th, 2022]
- 4 promising heart failure therapies interventional cardiologists should keep an eye on - Cardiovascular Business [Last Updated On: May 7th, 2022] [Originally Added On: May 7th, 2022]
- LEXEO Therapeutics Announces Data Presentations at the 25th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting - Yahoo Finance [Last Updated On: May 7th, 2022] [Originally Added On: May 7th, 2022]
- Ventricular structure and function in hypertensive patients | IJGM - Dove Medical Press [Last Updated On: May 7th, 2022] [Originally Added On: May 7th, 2022]
- Effects of diabetes mellitus on left ventricular function and remodeling in hypertensive patients with heart failure with reduced ejection fraction:... [Last Updated On: May 7th, 2022] [Originally Added On: May 7th, 2022]
- Cardior Announces CE Marking of CardiorHealth miR-132 PCR Kit Used in Ongoing HF-REVERT Phase 2 Clinical Study - Business Wire [Last Updated On: September 12th, 2022] [Originally Added On: September 12th, 2022]